Tapewire

Nasdaq · USD

NEUP

Neuphoria Therapeutics Inc.

Export transactions ↓
Tapewire entity
7639
SEC CIK
0001191070
Parsed reports
20

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 20, 2026 Filed Jan 21, 2026 16:01 UTC
Fisher AlanDirector
GrantRestricted Stock Units · Derivative 17,073 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-006172 · ownership.xml · derivative · entry 1

Fisher Alan · CIK 0002028654 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,731

Underlying: Common Stock · 17,073 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.

F2 · derivative.exercise_price: The grant of RSUs is pursuant to the Company's Board of Directors annual remuneration policy.

F3 · derivative.exercise_date: Subject to the Reporting Person's continuous service to the Company through the first of the following dates: (a) the day prior to the Company' next annual shareholder meeting (which is expected to be no later than December 15, 2026) or (b) the effective date of a Change in Control of the Company, the RSUs shall fully vest.

F3 · derivative.expiration_date: Subject to the Reporting Person's continuous service to the Company through the first of the following dates: (a) the day prior to the Company' next annual shareholder meeting (which is expected to be no later than December 15, 2026) or (b) the effective date of a Change in Control of the Company, the RSUs shall fully vest.

Read SEC document
January 20, 2026 Filed Jan 21, 2026 16:01 UTC GrantRestricted Stock Units · Derivative 8,537 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-006171 · ownership.xml · derivative · entry 1

Davies Peter Miles Winston · CIK 0002030200 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,320

Underlying: Common Stock · 8,537 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.

F2 · derivative.exercise_price: The grant of RSUs is pursuant to the Company's Board of Directors annual remuneration policy.

F3 · derivative.exercise_date: Subject to the Reporting Person's continuous service to the Company through the first of the following dates: (a) the day prior to the Company' next annual shareholder meeting (which is expected to be no later than December 15, 2026) or (b) the effective date of a Change in Control of the Company, the RSUs shall fully vest.

F3 · derivative.expiration_date: Subject to the Reporting Person's continuous service to the Company through the first of the following dates: (a) the day prior to the Company' next annual shareholder meeting (which is expected to be no later than December 15, 2026) or (b) the effective date of a Change in Control of the Company, the RSUs shall fully vest.

Read SEC document
January 20, 2026 Filed Jan 21, 2026 16:01 UTC GrantRestricted Stock Units · Derivative 8,537 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-006173 · ownership.xml · derivative · entry 1

Wilson David Ian · CIK 0002028949 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,412

Underlying: Common Stock · 8,537 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.

F2 · derivative.exercise_price: The grant of RSUs is pursuant to the Company's Board of Directors annual remuneration policy.

F3 · derivative.exercise_date: Subject to the Reporting Person's continuous service to the Company through the first of the following dates: (a) the day prior to the Company' next annual shareholder meeting (which is expected to be no later than December 15, 2026) or (b) the effective date of a Change in Control of the Company, the RSUs shall fully vest.

F3 · derivative.expiration_date: Subject to the Reporting Person's continuous service to the Company through the first of the following dates: (a) the day prior to the Company' next annual shareholder meeting (which is expected to be no later than December 15, 2026) or (b) the effective date of a Change in Control of the Company, the RSUs shall fully vest.

Read SEC document
January 20, 2026 Filed Jan 21, 2026 16:01 UTC
Ryan JaneDirector
GrantRestricted Stock Units · Derivative 8,537 $0.00 $0.00
Disclosure

SEC source: 0001213900-26-006170 · ownership.xml · derivative · entry 1

Ryan Jane · CIK 0002028936 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,550

Underlying: Common Stock · 8,537 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.1.

F2 · derivative.exercise_price: The grant of RSUs is pursuant to the Company's Board of Directors annual remuneration policy.

F3 · derivative.exercise_date: Subject to the Reporting Person's continuous service to the Company through the first of the following dates: (a) the day prior to the Company' next annual shareholder meeting (which is expected to be no later than December 15, 2026) or (b) the effective date of a Change in Control of the Company, the RSUs shall fully vest.

F3 · derivative.expiration_date: Subject to the Reporting Person's continuous service to the Company through the first of the following dates: (a) the day prior to the Company' next annual shareholder meeting (which is expected to be no later than December 15, 2026) or (b) the effective date of a Change in Control of the Company, the RSUs shall fully vest.

Read SEC document
October 21, 2025 Filed Oct 23, 2025 23:49 UTC PurchaseCommon stock, $0.00001 par value per share 639,110 $5.14 $3,283,108.07
Disclosure

SEC source: 0000902664-25-004536 · ownership.xml · nonDerivative · entry 1

Lynx1 Capital Management LP · CIK 0001910456 · 10% owner

Nichols Weston · CIK 0001746376 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 875,328

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.96 to $5.20 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

F2 · ownership.nature: The securities to which this filing relates are held directly by Lynx1 Master Fund LP to which Lynx1 Capital Management LP (the "Investment Manager") serves as investment manager. Weston Nichols ("Mr. Nichols") is the sole member of Lynx1 Capital Management GP LLC, the general partner of the Investment Manager. Each of the Investment Manager and Mr. Nichols disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any.

Read SEC document
August 27, 2025 Filed Sep 2, 2025 11:02 UTC
Papapetropoulos SpyrosDirector · President and CEO
GrantEmployee Stock Option (Right-to- Buy) · Derivative 34,559 $8.27 Strike: $8.27 $285,802.93
Disclosure

SEC source: 0001213900-25-082904 · ownership.xml · derivative · entry 1

Papapetropoulos Spyros · CIK 0001832694 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,088

Underlying: Common Stock · 34,559 shares

Expires 2035-08-27

F1 · derivative.exercise_date: Subject to the Reporting Person's continuing service with the Company, the options shall vest on a monthly basis over a four-year period at the rate of 2.0833% of the shares of Common Stock on the last day of each month following August 1, 2025 until the options are fully vested.

Read SEC document
April 16, 2025 Filed Apr 18, 2025 08:03 UTC GrantRestricted Stock Units · Derivative 6,783 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-033143 · ownership.xml · derivative · entry 1

Davies Peter Miles Winston · CIK 0002030200 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,783

Underlying: Common Stock · 6,783 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.

F2 · derivative.exercise_date: Subject to the Reporting Person's continuous service to the Company through the day prior to the Company' next annual shareholder meeting (which is expected to be no later than November 30, 2025), the RSUs shall fully vest at 5:01 PM EST on the day prior to the Company's next annual shareholder meeting.

F2 · derivative.expiration_date: Subject to the Reporting Person's continuous service to the Company through the day prior to the Company' next annual shareholder meeting (which is expected to be no later than November 30, 2025), the RSUs shall fully vest at 5:01 PM EST on the day prior to the Company's next annual shareholder meeting.

Read SEC document
April 16, 2025 Filed Apr 18, 2025 08:00 UTC
Fisher AlanDirector
GrantRestricted Stock Units · Derivative 13,566 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-033139 · ownership.xml · derivative · entry 1

Fisher Alan · CIK 0002028654 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,658

Underlying: Common Stock · 13,566 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.

F2 · derivative.exercise_date: Subject to the Reporting Person's continuous service to the Company through the day prior to the Company' next annual shareholder meeting (which is expected to be no later than November 30, 2025), the RSUs shall fully vest at 5:01 PM EST on the day prior to the Company's next annual shareholder meeting.

F2 · derivative.expiration_date: Subject to the Reporting Person's continuous service to the Company through the day prior to the Company' next annual shareholder meeting (which is expected to be no later than November 30, 2025), the RSUs shall fully vest at 5:01 PM EST on the day prior to the Company's next annual shareholder meeting.

Read SEC document
April 16, 2025 Filed Apr 18, 2025 08:01 UTC GrantRestricted Stock Units · Derivative 6,783 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-033140 · ownership.xml · derivative · entry 1

Wilson David Ian · CIK 0002028949 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,875

Underlying: Common Stock · 6,783 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.

F2 · derivative.exercise_date: Subject to the Reporting Person's continuous service to the Company through the day prior to the Company' next annual shareholder meeting (which is expected to be no later than November 30, 2025), the RSUs shall fully vest at 5:01 PM EST on the day prior to the Company's next annual shareholder meeting.

F2 · derivative.expiration_date: Subject to the Reporting Person's continuous service to the Company through the day prior to the Company' next annual shareholder meeting (which is expected to be no later than November 30, 2025), the RSUs shall fully vest at 5:01 PM EST on the day prior to the Company's next annual shareholder meeting.

Read SEC document
April 16, 2025 Filed Apr 18, 2025 08:02 UTC
Ryan JaneDirector
GrantRestricted Stock Units · Derivative 6,783 $0.00 $0.00
Disclosure

SEC source: 0001213900-25-033142 · ownership.xml · derivative · entry 1

Ryan Jane · CIK 0002028936 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,013

Underlying: Common Stock · 6,783 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.

F2 · derivative.exercise_date: Subject to the Reporting Person's continuous service to the Company through the day prior to the Company' next annual shareholder meeting (which is expected to be no later than November 30, 2025), the RSUs shall fully vest at 5:01 PM EST on the day prior to the Company's next annual shareholder meeting.

F2 · derivative.expiration_date: Subject to the Reporting Person's continuous service to the Company through the day prior to the Company' next annual shareholder meeting (which is expected to be no later than November 30, 2025), the RSUs shall fully vest at 5:01 PM EST on the day prior to the Company's next annual shareholder meeting.

Read SEC document
April 16, 2025 Filed Apr 18, 2025 12:04 UTC
Papapetropoulos SpyrosDirector · President and CEO
GrantEmployee Stock Option (Right-to-Buy) · Derivative 270,000 $5.16 Strike: $5.16 $1,393,200.00
Disclosure

SEC source: 0001213900-25-033144 · ownership.xml · derivative · entry 1

Papapetropoulos Spyros · CIK 0001832694 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 282,529

Underlying: Common Stock · 270,000 shares

Expires 2035-04-16

F1 · derivative.exercise_date: Subject to the Reporting Person's continuing service with the Company, the options shall vest on a monthly basis over a three-year period at the rate of 2.78% of the shares of Common Stock on the last day of each month following September 1, 2024 until the options are vested.

Read SEC document
April 16, 2025 Filed May 19, 2025 20:40 UTC Amendment
Papapetropoulos SpyrosDirector · President and CEO
GrantEmployee Stock Option (Right-to-Buy) · Derivative 27,000 $5.16 Strike: $5.16 $139,320.00
Disclosure

SEC source: 0001213900-25-045445 · ownership.xml · derivative · entry 1

Papapetropoulos Spyros · CIK 0001832694 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,529

Underlying: Common Stock · 27,000 shares

Expires 2035-04-16

F1 · shares: The original Form 4, filed on April 17, 2025, is amended by this Form 4/A solely to correct a clerical error, which resulted in misreporting the number of derivative securities acquired (Item 5) and amount of securities underlying the derivative securities (Item 7) as 270,000 when the actual number of derivative securities acquired and amount of securities underlying the derivative securities was 27,000. With the correction of the clerical error, the number of derivative securities beneficially owned following the reported transaction (Item 9) is 39,529 shares.

F2 · derivative.exercise_date: Subject to the Reporting Person's continuing service with the Company, the options shall vest on a monthly basis over a three-year period at the rate of 2.78% of the shares of Common Stock on the last day of each month following September 1, 2024 until the options are vested.

F1 · derivative.underlying_shares: The original Form 4, filed on April 17, 2025, is amended by this Form 4/A solely to correct a clerical error, which resulted in misreporting the number of derivative securities acquired (Item 5) and amount of securities underlying the derivative securities (Item 7) as 270,000 when the actual number of derivative securities acquired and amount of securities underlying the derivative securities was 27,000. With the correction of the clerical error, the number of derivative securities beneficially owned following the reported transaction (Item 9) is 39,529 shares.

F1 · balance_after: The original Form 4, filed on April 17, 2025, is amended by this Form 4/A solely to correct a clerical error, which resulted in misreporting the number of derivative securities acquired (Item 5) and amount of securities underlying the derivative securities (Item 7) as 270,000 when the actual number of derivative securities acquired and amount of securities underlying the derivative securities was 27,000. With the correction of the clerical error, the number of derivative securities beneficially owned following the reported transaction (Item 9) is 39,529 shares.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.